Tutzing, Germany

Jurgen Rasch

This inventor holds 1 USPTO granted patent. Top assignee: Boehringer Mannheim Gmbh. Active years: 1988.


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 7(Granted Patents)


Company Filing History:


Years Active: 1988

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Jurgen Rasch: Innovator in Thyroxin-Binding Research

Introduction

Jurgen Rasch is a notable inventor based in Tutzing, Germany. He has made significant contributions to the field of biochemistry, particularly in the area of hormone binding proteins. His work has implications for medical diagnostics and therapeutic applications.

Latest Patents

Jurgen Rasch holds a patent for a process that determines the binding capacity of thyroxin-binding globulin (TBG). This innovative process utilizes the principle of heterogeneous enzyme immunoassay. In this method, a serum sample is incubated with enzyme-labelled T4 or T3 and an immobilized antibody against TBG or T4. The phases are then separated, and the labeling enzyme is measured in one of the phases. This patent represents a significant advancement in the understanding and measurement of hormone binding in the human body.

Career Highlights

Rasch has been associated with Boehringer Mannheim GmbH, a company known for its contributions to the field of diagnostics and biochemistry. His work at the company has allowed him to collaborate with other experts in the field, enhancing the impact of his research.

Collaborations

Some of his notable coworkers include Brigitte Draeger and Winfried Albert. Their collaborative efforts have contributed to the advancement of research in hormone binding and related areas.

Conclusion

Jurgen Rasch's innovative work in the field of thyroxin-binding globulin has paved the way for improved diagnostic methods. His contributions continue to influence the landscape of biochemistry and medical research.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…